Figure 8.
The differential percent of monocytes associated with the SCD membrane increased with each subsequent SCD treatment A, B, and C to 15 ± 4.5, 18 ± 3.2, and 33 ± 8.7%, respectively. For treatments B and C, values are significantly higher than that of the systemic circulation value, prior to SCD treatment, of 4.0 ± 0.9% (p = 0.012 (∗) and 0.03 (∗∗) for B and C versus systemic, resp., n = 3).